National Bank Of Canada Neogenomics Inc Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Neogenomics Inc stock. As of the latest transaction made, National Bank Of Canada holds 441 shares of NEO stock, worth $6,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
441
Previous 441
-0.0%
Holding current value
$6,425
Previous $6,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$287 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$205 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$100 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$96.2 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$95.3 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.83B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...